This trial may sound like great news until you realize that now every other country will be waiting for results before granting an EUA. That means probably nothing from India, Canada, or the Philippines (not to mention all the other red herrings) until interim analysis from Brazil. They haven't stuck their necks out for Leronlimab yet and now they have the perfect excuse to wait.